Swiss National Bank
NXTM

Swiss National Bank’s NxStage Medical Inc. NXTM Stock Holding History

Swiss National Bank’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-136,400
Closed -$3.9M – 2521
2018
Q4 		$3.9M Hold
136,400
– – 0.01% 1131
2018
Q3 		$3.8M Hold
136,400
– – ﹤0.01% 1295
2018
Q2 		$3.81M Hold
136,400
– – ﹤0.01% 1272
2018
Q1 		$3.39M Buy
136,400
+13,700
+11% +$333K ﹤0.01% 1294
2017
Q4 		$2.97M Hold
122,700
– – ﹤0.01% 1397
2017
Q3 		$3.39M Buy
122,700
+13,000
+12% +$347K ﹤0.01% 1280
2017
Q2 		$2.75M Buy
109,700
+3,600
+3% +$89.1K ﹤0.01% 1373
2017
Q1 		$2.85M Hold
106,100
– – ﹤0.01% 1343
2016
Q4 		$2.78M Buy
106,100
+2,800
+3% +$69.2K ﹤0.01% 1343
2016
Q3 		$2.58M Sell
103,300
-3,500
-3% -$81.6K ﹤0.01% 1343
2016
Q2 		$2.31M Buy
106,800
+14,200
+15% +$253K ﹤0.01% 1400
2016
Q1 		$1.34M Buy
92,600
+18,100
+24% +$303K ﹤0.01% 1718
2015
Q4 		$1.63M Hold
74,500
– – ﹤0.01% 1476
2015
Q3 		$1.18M Buy
74,500
+9,400
+14% +$151K ﹤0.01% 1673
2015
Q2 		$930K Sell
65,100
-3,800
-6% -$64.4K ﹤0.01% 1829
2015
Q1 		$1.19M Buy
68,900
+1,700
+3% +$30K ﹤0.01% 1669
2014
Q4 		$1.21M Hold
67,200
– – ﹤0.01% 1624
2014
Q3 		$882K Hold
67,200
– – ﹤0.01% 1734
2014
Q2 		$966K Buy
67,200
+5,100
+8% +$66.6K ﹤0.01% 1737
2014
Q1 		$791K Buy
62,100
+13,700
+28% +$179K ﹤0.01% 1847
2013
Q4 		$484K Hold
48,400
– – ﹤0.01% 2012
2013
Q3 		$637K Sell
48,400
-2,300
-5% -$30.2K ﹤0.01% 1783
2013
Q2 		$724K Buy
+50,700
New +$638K ﹤0.01% 1656

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Swiss National Bank's NXTM Position: Q1 2019 in Review

Swiss National Bank sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 136,400 shares — an estimated $3.9M sold.

Swiss National Bank first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $3.9M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Swiss National Bank reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Swiss National Bank sold 136,400 NxStage Medical Inc. shares in Q1 2019, an estimated $3.9M.
  • Swiss National Bank first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Swiss National Bank's NxStage Medical Inc. position peaked at $3.9M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Swiss National Bank's 13F filing for Q1 2019, filed 10 May 2019.